GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bright Minds Biosciences DRUG · USD

Health Care · US listing · 🇺🇸 United States

Compare

23.11

+1.63%

Close of 13 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Bright Minds Biosciences — daily DRUG Delayed
Market value
$226.8m
Last close × shares
Volume
118.6k
Shares, 13 Nov 2026

About Bright Minds Biosciences

Its shares trade under the ticker DRUG. It has been listed since 22 March 2021.

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.

Figures and description from our data supplier, not checked against the company's own report.

More about Bright Minds Biosciences →

Latest on Bright Minds Biosciences

Our reporting

Next results

22 Dec 2026

Due on 22 Dec 2026. Analysts expect earnings of -1.07 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Bright Minds Biosciences's ticker?

Bright Minds Biosciences trades as DRUG on its US listing, under ISIN CA10919W1086.

What was Bright Minds Biosciences's last closing price?

23.11 on 13 Nov 2026. The figure is in USD and is never converted.

When does Bright Minds Biosciences next report results?

Results are expected on 22 Dec 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.